Table 1 The BCLC staging
From: Late presentation of sorafenib-associated rash: a case report
| Â | Â | Tumor Status | Â | Â |
|---|---|---|---|---|
BCLC Stage | PS | Tumor Stage | Okuda Stage | Liver function |
Stage A: early | Â | Â | Â | Â |
A1 | 0 | Single, <5 cm | I | No portal HT, normal bilirubin |
A2 | 0 | Single, <5 cm | I | Portal HT, normal bilirubin |
A3 | 0 | Single, <5 cm | I | Portal HT, normal bilirubin |
A4 | 0 | 3 tumors, <3 cm | I-II | Child-Pugh A-B |
Stage B | Â | Â | Â | Â |
Intermediate HCC | 0 | Large multinodular | I-II | Child-Pugh A-B |
Stage C: advanced | 1-2 | Vascular invasion/extrahepatic spread | I-II | Child-Pugh A-B |
Stage D: end stage | 3-4 | Any | III | Child-Pugh C |